MEXICO CITY – Roche Mexico reported Wednesday the arrival of 52,000 units of Tamiflu (Oseltamivir) to combat influenza, in addition to the five thousand cases that were received in Mexico Feb. 29.
The laboratory stated that in the coming hours 33,000 units will reach the country, adding up to a total of 90,000 units in response to the current high demand for the drug.
It specifies that it delivered the drug to the authorized independent distributors, who are responsible for placing them in pharmacies nationwide.
The laboratory said in a statement that with the arrival of more units of the medication,”the collaboration with Mexican health authorities for the health of Mexicans is strengthened.”
The company based in Basel, Switzerland, added that Tamiflu has been sold in Mexico since 1999 and is available at chain pharmacies that sell patent drugs throughout Mexico.
To address the supply problem generated by the increase in demand for the drug in recent days, the Health Secretariat reported that there was a commitment for 20,000 units of treatment to be available by Mar. 6, for the private sector and 65,000 for the public institutions.
In a statement, the agency demanded that Roche correct the supply of the product on the appointed date, and in case of failure to do so, the appropriate sanction will be applied.
The drug Oseltamivir must be prescribed by a doctor, and its only indication is the treatment of respiratory illness caused by the influenza virus, authorities warned.
— gob.mx (@gobmx) March 2, 2016